Atlanta, GA, United States of America

Hairuo Peng


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hairuo Peng in Seco-Cholestane Derivatives

Introduction

Hairuo Peng is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on seco-cholestane derivatives. His research focuses on developing novel compounds that have potential applications in cancer treatment.

Latest Patents

Hairuo Peng holds a patent for "Seco-cholestane derivatives and methods of making the same." This invention is directed towards novel seco-cholestane derivatives, including C5- and C8-substituted variants. The compounds developed through this research exhibit CDC25 phosphatase inhibition properties and demonstrate anti-cancer activity. This patent highlights the potential of these derivatives in pharmaceutical applications.

Career Highlights

Hairuo Peng is affiliated with the Georgia Tech Research Corporation, where he conducts his research. His work at this institution has allowed him to explore innovative solutions in the field of medicinal chemistry. With a focus on developing effective pharmaceutical compositions, he continues to contribute to advancements in cancer treatment.

Collaborations

Hairuo Peng collaborates with various professionals in his field, including his coworker Leon H. Zalkow. These collaborations enhance the research efforts and foster innovation in the development of new therapeutic compounds.

Conclusion

Hairuo Peng's work on seco-cholestane derivatives represents a significant advancement in pharmaceutical chemistry. His innovative approach and dedication to research have the potential to impact cancer treatment positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…